Edwards Lifesciences (EW) Other Working Capital Changes (2016 - 2025)
Edwards Lifesciences has reported Other Working Capital Changes over the past 17 years, most recently at -$8.1 million for Q4 2025.
- Quarterly results put Other Working Capital Changes at -$8.1 million for Q4 2025, down 146.82% from a year ago — trailing twelve months through Dec 2025 was $23.7 million (up 10.75% YoY), and the annual figure for FY2025 was $23.7 million, up 10.75%.
- Other Working Capital Changes for Q4 2025 was -$8.1 million at Edwards Lifesciences, down from $28.5 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for EW hit a ceiling of $72.3 million in Q4 2022 and a floor of -$33.2 million in Q3 2021.
- Median Other Working Capital Changes over the past 5 years was $2.6 million (2024), compared with a mean of $6.4 million.
- Biggest five-year swings in Other Working Capital Changes: crashed 629.63% in 2023 and later skyrocketed 2950.0% in 2025.
- Edwards Lifesciences' Other Working Capital Changes stood at $20.0 million in 2021, then soared by 261.5% to $72.3 million in 2022, then crashed by 104.43% to -$3.2 million in 2023, then soared by 640.62% to $17.3 million in 2024, then plummeted by 146.82% to -$8.1 million in 2025.
- The last three reported values for Other Working Capital Changes were -$8.1 million (Q4 2025), $28.5 million (Q3 2025), and $13.9 million (Q2 2025) per Business Quant data.